GB0227080D0 - Antibodies and uses thereof - Google Patents

Antibodies and uses thereof

Info

Publication number
GB0227080D0
GB0227080D0 GB0227080A GB0227080A GB0227080D0 GB 0227080 D0 GB0227080 D0 GB 0227080D0 GB 0227080 A GB0227080 A GB 0227080A GB 0227080 A GB0227080 A GB 0227080A GB 0227080 D0 GB0227080 D0 GB 0227080D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0227080A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Priority to GB0227080A priority Critical patent/GB0227080D0/en
Publication of GB0227080D0 publication Critical patent/GB0227080D0/en
Priority to EP03778499A priority patent/EP1565491B1/en
Priority to CA2506724A priority patent/CA2506724C/en
Priority to AT03778499T priority patent/ATE462727T1/en
Priority to DK03778499.8T priority patent/DK1565491T3/en
Priority to PCT/GB2003/005059 priority patent/WO2004046191A2/en
Priority to JP2004570309A priority patent/JP4869603B2/en
Priority to MXPA05005470A priority patent/MXPA05005470A/en
Priority to PT03778499T priority patent/PT1565491E/en
Priority to AU2003285500A priority patent/AU2003285500B8/en
Priority to SI200331827T priority patent/SI1565491T1/en
Priority to DE60331945T priority patent/DE60331945D1/en
Priority to ES03778499T priority patent/ES2357609T3/en
Priority to US10/535,873 priority patent/US20060099143A1/en
Priority to IL168646A priority patent/IL168646A/en
Priority to HK06102455.8A priority patent/HK1080869A1/en
Priority to US11/429,147 priority patent/US8394381B2/en
Priority to US11/890,213 priority patent/US20080019963A1/en
Priority to US11/888,855 priority patent/US20080166295A1/en
Priority to IL204453A priority patent/IL204453A/en
Priority to CY20101100595T priority patent/CY1110661T1/en
Priority to JP2011207275A priority patent/JP5336566B2/en
Ceased legal-status Critical Current

Links

GB0227080A 2002-11-20 2002-11-20 Antibodies and uses thereof Ceased GB0227080D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GB0227080A GB0227080D0 (en) 2002-11-20 2002-11-20 Antibodies and uses thereof
US10/535,873 US20060099143A1 (en) 2002-11-20 2003-11-20 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis
SI200331827T SI1565491T1 (en) 2002-11-20 2003-11-20 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition of angiogenesis
ES03778499T ES2357609T3 (en) 2002-11-20 2003-11-20 ANTIBODIES BINDING TO HUMAN MAGIC ROUNDABOUT (MR), POLYPEPTIDES AND ITS USE FOR THE INHIBITION OF ANGIOGENESIS.
AT03778499T ATE462727T1 (en) 2002-11-20 2003-11-20 HUMAN ROUNDABOUT BINDING ANTIBODIES, POLYPEPTIDES AND THEIR USE FOR INHIBITING ANGIOGENESIS
DK03778499.8T DK1565491T3 (en) 2002-11-20 2003-11-20 Antibodies that bind to human magic roundabout (MRI), polypeptides and their uses for inhibiting angiogenesis
PCT/GB2003/005059 WO2004046191A2 (en) 2002-11-20 2003-11-20 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis
JP2004570309A JP4869603B2 (en) 2002-11-20 2003-11-20 Antibodies, polypeptides and uses thereof
MXPA05005470A MXPA05005470A (en) 2002-11-20 2003-11-20 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis.
PT03778499T PT1565491E (en) 2002-11-20 2003-11-20 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition of angiogenesis
AU2003285500A AU2003285500B8 (en) 2002-11-20 2003-11-20 Antibodies binding to human magic roundabout (MR), polypeptides and uses thereof for inhibition of angiogenesis
EP03778499A EP1565491B1 (en) 2002-11-20 2003-11-20 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition of angiogenesis
DE60331945T DE60331945D1 (en) 2002-11-20 2003-11-20 ANTIBODIES BINDING TO HUMAN ROUNDABOUT, POLYPEPTIDES, AND THEIR USE FOR THE INHIBITION OF ANGIOGENESIS
CA2506724A CA2506724C (en) 2002-11-20 2003-11-20 Antibodies, polypeptides and uses thereof
IL168646A IL168646A (en) 2002-11-20 2005-05-17 Antibodies binding to human magic roundabout (mr) and uses thereof for inhibition of angiogenesis
HK06102455.8A HK1080869A1 (en) 2002-11-20 2006-02-23 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition of angiogenesis
US11/429,147 US8394381B2 (en) 2002-11-20 2006-05-05 Antibodies, polypeptides and uses thereof
US11/890,213 US20080019963A1 (en) 2002-11-20 2007-08-02 Antibodies, polypeptides and uses thereof
US11/888,855 US20080166295A1 (en) 2002-11-20 2007-08-02 Antibodies, polypeptides and uses thereof
IL204453A IL204453A (en) 2002-11-20 2010-03-11 Use of human magic roundabout (mr) for the preparation of medicaments for inhibition of endothelial cell migration and/or proliferation
CY20101100595T CY1110661T1 (en) 2002-11-20 2010-06-29 ANTIBODIES CONNECTED TO THE HUMAN MAGIC MILL (MR), POLYPALPTESES AND THEIR USES TO REDUCE THE VASCULAR
JP2011207275A JP5336566B2 (en) 2002-11-20 2011-09-22 Antibodies, polypeptides and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0227080A GB0227080D0 (en) 2002-11-20 2002-11-20 Antibodies and uses thereof

Publications (1)

Publication Number Publication Date
GB0227080D0 true GB0227080D0 (en) 2002-12-24

Family

ID=9948191

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0227080A Ceased GB0227080D0 (en) 2002-11-20 2002-11-20 Antibodies and uses thereof

Country Status (2)

Country Link
ES (1) ES2357609T3 (en)
GB (1) GB0227080D0 (en)

Also Published As

Publication number Publication date
ES2357609T3 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
IL225633A0 (en) Anti-alpha-v-beta - 6 antibodies and uses thereof
EP1551447A4 (en) Anti-addl antibodies and uses thereof
HK1248731A1 (en) Immunoglobulin variants and uses thereof
EP1551877A4 (en) Taci antibodies and uses thereof
AU2003299778A8 (en) Antibodies against gpr64 and uses thereof
EP1539941A4 (en) Adzymes and uses thereof
EP1494693A4 (en) Cripto-specific antibodies
IL172871A0 (en) Rg1 antibodies and uses thereof
PL375405A1 (en) Antibodies
EP1699485A4 (en) Anti-hydroxylase antibodies and uses thereof
IL172510A0 (en) Antibodies and uses thereof
IL166063A0 (en) Antibodies and uses thereof
EP1589033A4 (en) Antibody and use thereof
AU2003231827A8 (en) Pseudo-tissues and uses thereof
AU2003249533A8 (en) Neoplasm specific antibodies and uses thereof
AU2003298739A8 (en) Intermedin and its uses
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
GB0226878D0 (en) Antibodies
AU2003228397A8 (en) Hausp-p53 interaction and uses thereof
AU2003216442A8 (en) Enkurin and uses thereof
EP1627888A4 (en) Antibody and use thereof
GB0227080D0 (en) Antibodies and uses thereof
AU2003270518A8 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof
EP1557430A4 (en) Antibody and utilization of the same
AU2003263751A8 (en) Novel proteins and their uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)